Login / Signup

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.

Djamila ChemlalEmmanuel VarletAmelie MachuraSara OvejeroGuilhem RequirandNicolas RobertGuillaume CartronElina AlaterreCaroline BretLaure VincentCharles HerbauxGiacomo CavalliAngélique BruyerHugues De BoussacJérôme Moreaux
Published in: Leukemia (2023)
Keyphrases
  • multiple myeloma
  • nk cells
  • poor prognosis
  • long non coding rna
  • signaling pathway
  • drug delivery